NGS reading for Media Free DNA
ProcedureNGS reading for Media Free DNA instead of blstomer biopsy
NCT Number: NCT02884063
In the way for developing and optimizing protocol to be used as non- invasive methodology used as routine testing for PGS.
This protocol is to be adapted to replace the using of life embryo cells for genetic testing and aneuploidy study as well as for any type of genetic testing including single gene disorder or HLA typing or study.
Looking for future studies?
Notify Me20 year–45 year
All sexes
Observational
Compare 100 embryos studied using NGS for chromosomal aneuploidies, and compare the results came from free media DNA with this results.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
NGS reading for Media Free DNA instead of blstomer biopsy
Time frame: 2 years
reading amplified DNA using NGS
Time frame: 2 years
Free DNA isolation and amplification using WGA
Time frame: 2 years
compare the obtained result with the results provided collected for the same embryo using its blastomer for PGS
Al Baraka Fertility Hospital
Other
Utilizing Free DNA in Embryo Culture Media for Preimplantation Genetic Screening
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00004351
22q11 Deletion Syndrome, Abnormalities, Multiple
Houston, Texas, United States
View Trial DetailsNCT03179631
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn
Phoenix, Arizona, United States
View Trial DetailsNCT03655678
Anemia, Anemia, Hemolytic
Palo Alto, California, United States
View Trial DetailsNCT05479981
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DM1
Los Angeles, California, United States
View Trial Details